D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PRTK holding history
Paratek Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PRTK overviewAll 13F holders of PRTKFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −396,076−100.0% | Sold out | Holders |
| Q2 2023 | 396,076 | $875.3K | <0.1% | +42,577+12.0% | Added | Holders |
| Q1 2023 | 353,499 | $897.9K | <0.1% | −39,197−10.0% | Reduced | Holders |
| Q4 2022 | 392,696 | $734.3K | <0.1% | +83,132+26.9% | Added | Holders |
| Q3 2022 | 309,564 | $795.0K | <0.1% | +191,355+161.9% | Added | Holders |
| Q2 2022 | 118,209 | $228.0K | <0.1% | +41,278+53.7% | Added | Holders |
| Q1 2022 | 76,931 | $228.0K | <0.1% | +48,518+170.8% | Added | Holders |
| Q4 2021 | 28,413 | $128.0K | <0.1% | −27,094−48.8% | Reduced | Holders |
| Q3 2021 | 55,507 | $270.0K | <0.1% | −51,401−48.1% | Reduced | Holders |
| Q2 2021 | 106,908 | $729.0K | <0.1% | −109,745−50.7% | Reduced | Holders |
| Q1 2021 | 216,653 | $1.53M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.